Ana V. Ocana - Publications

A New Guanidine-Core Small-Molecule Compound as a Potential Antimicrobial Agent against Resistant Bacterial Strains.

Journal: Antibiotics (Basel, Switzerland)

Published: May 30, 2024

Methacrylate Cationic Nanoparticles Activity against Different Gram-Positive Bacteria.

Journal: Antibiotics (Basel, Switzerland)

Published: February 18, 2023

A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa.

Journal: Laryngoscope investigative otolaryngology

Published: November 23, 2021

A novel bis(pyrazolyl)methane compound as a potential agent against Gram-positive bacteria.

Journal: Scientific reports

Published: June 14, 2021

Medical Oncology Workload in Europe: One Continent, Several Worlds.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 22, 2019

Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 19, 2018

Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 24, 2017

Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: July 12, 2017

Antimicrobial evaluation of quaternary ammonium polyethyleneimine nanoparticles against clinical isolates of pathogenic bacteria.

Journal: IET nanobiotechnology

Published: December 10, 2015

Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies.

Journal: Cancer treatment reviews

Published: October 09, 2015

Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node.

Journal: Oncogene

Published: January 28, 2015

Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 04, 2015